학술논문
Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis
Document Type
Article
Author
Source
In: Neurology: Neuroimmunology and NeuroInflammation . (Neurology: Neuroimmunology and NeuroInflammation, 29 November 2022, 9(6))
Subject
Language
English
ISSN
23327812